Evaluation of Patients after Extraperitoneal Lymph Node Dissection and Subsequent Radiotherapy for Cervical Cancer

• Published in: Gynecologic oncology Vol. 84; no. 2; pp. 321 - 326
• Main Authors: Hasenburg, Annette, Salama, Joseph K., Van, T.John, Amosson, Chad, Chiu, J.Kam, Kieback, Dirk G.
• Format: Journal Article
• Language: English
• Published: San Diego, CA Elsevier Inc 01.02.2002; Elsevier
• Subjects: Adult; Biological and medical sciences; cervical cancer; Combined Modality Therapy; extended field; extraperitoneal lymph node dissection; Female; Humans; Hysterectomy; Lymph Node Excision - adverse effects; Lymph Node Excision - methods; lymph nodes; Lymph Nodes - pathology; Lymph Nodes - surgery; Medical sciences; Middle Aged; Neoplasm Staging; radiotherapy; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Surgery of the genital tract and mammary gland; Time Factors; toxicity; Uterine Cervical Neoplasms - drug therapy; Uterine Cervical Neoplasms - radiotherapy; Uterine Cervical Neoplasms - surgery; toxicity; radiotherapy; lymph nodes; cervical cancer; extended field; extraperitoneal lymph node dissection; Performance evaluation; Human; Carcinoma; Lymph node; Malignant tumor; Uterine cervix; Hysterectomy; Radiotherapy; Female genital diseases; Clinical stage; Treatment; Surgery; Female; Diagnosis; Preoperative; Technique; Dissection; Uterine cervix diseases

Objective. The presence of nodal metastases is the most important prognostic factor in cervical cancer. To adjust our therapy based on the true extent of the patient's disease, we performed an extraperitoneal lymph node dissection (EPLND) in all patients with cervical cancer prior to radiothera...